×
About 21,932 results

People of Any Age with Underlying Medical Conditions
https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html

COVID-19 is a new disease. Currently there are limited data and information about the impact of underlying medical conditions and whether they increase the risk for severe illness from COVID-19. Based on what we know at this time, people with the following conditions might be at an increased risk for severe illness from COVID-19:

CDC Activities and Initiatives Supporting the COVID-19 Response and the President’s Plan for Opening America Up Again
https://www.cdc.gov/coronavirus/2019-ncov/downloads/php/CDC-Activities-Initiatives-for-COVID-19-Response.pdf

The principal objectives of COVID-19 surveillance are to monitor the spread and intensity of the pandemic, to enable contact tracing to slow transmission, and to identify disease clusters requiring special intervention. Secondary objectives include understanding the severity and spectrum of disease, identifying risk factors for and methods of preventing infection, and producing data essentia...

NHLBI's COVID-19 Guidance for Practicing Clinicians
https://www.nhlbi.nih.gov/coronavirus/nhlbi-covid-19-guidance-practicing-clinicians
NIH

Health care providers seeking information about appropriate coronavirus disease 2019 (COVID-19) treatment may now consult treatment guidelines developed by a panel of U.S. physicians, statisticians, and other experts. These guidelines are based on published and preliminary data and the clinical expertise of the panelists, many of whom are frontline clinicians caring for patients during the rapi...

COVID-19: Guidelines for Myasthenia Gravis Management and Other Neuromuscular Disorders
https://journals.lww.com/neurotodayonline/blog/breakingnews/pages/post.aspx?PostID=950

​If your patients have myasthenia gravis, should they come in for an infusion therapy? Is it safe to start patients on a new B-cell depleting therapy? And should patients stop their immunosuppressive therapies? As the COVID-19 pandemic rages on, neurologists working with patients with neuromuscular diseases are fielding these questions with little overall specific data on the overall effect of ...

AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19
https://www.gastrojournal.org/article/S0016-5085(20)30593-X/pdf?referrer=https://www.jwatch.org/na51575/2020/05/13/prevalence-gi-and-liver-manifestations-covid-19-infection
Gastroenterology

Multiple gastrointestinal (GI) symptoms including diarrhea, nausea/vomiting, and abdominal pain, as well liver enzyme abnormalities have been variably reported in patients with COVID-19. The AGA) Institute Clinical Guideline Committee and Clinical Practice Updates Committee performed a systematic review and meta-analysis of international data on GI and liver manifestations of COVID-19.

2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or...
https://www.jacc.org/doi/10.1016/j.jacc.2020.09.011
Journal of the American College of Cardiology; Kumbhani DJ, .

The American College of Cardiology (ACC) has a long history of developing documents (e.g., decision pathways, health policy statements, appropriate use criteria) to provide members with guidance on both clinical and nonclinical topics relevant to cardiovascular care. In most circumstances, these documents have been created to complement clinical practice guidelines and to inform clinicians abou...

NCCN: Cancer and COVID-19 Vaccination
https://www.nccn.org/covid-19/pdf/COVID-19_Vaccination_Guidance_V1.0.pdf
NCCN COVID-19 Vaccination Advisory Committee

Jan 20th, 2021 - Patients with cancer should be prioritized for vaccination (CDC priority group 1b/c) and should be immunized when vaccination is available to them. Immunization is recommended for all patients receiving active therapy, with the understanding that there are limited safety and efficacy data in these patients.

The COVID-19 Treatment Guidelines Panel’s Statement on the Use of Ivermectin for the Treatment of COVID-19
https://www.covid19treatmentguidelines.nih.gov/statement-on-ivermectin
National Institutes of Health (NIH)

The COVID-19 Treatment Guidelines Panel (the Panel) has determined that currently there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19. Results from adequately powered, well-designed, and well-conducted clinical trials are needed to provide more specific, evidence-based guidance on the role of ivermectin for the treatment of COVID-19.

Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: U...
https://doi.org/10.1001/jama.2018.14741
JAMA , Curry SJ et. al.

Oct 25th, 2018 - Intimate partner violence (IPV) and abuse of older or vulnerable adults are common in the United States but often remain undetected. In addition to the immediate effects of IPV, such as injury and death, there are other health consequences, many with long-term effects, including development of mental health conditions such as depression, posttraumatic stress disorder, anxiety disorders, substan...

Recommendations for Prevention and Control of Influenza in Children, 2017 - 2018.
https://doi.org/10.1542/peds.2017-2550
Pediatrics

Sep 5th, 2017 - This statement updates the recommendations for routine use of the seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The American Academy of Pediatrics recommends annual seasonal influenza immunization for everyone 6 months and older, including children and adolescents. Highlights for the upcoming 2017-2018 season include the followin...

Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations.
https://doi.org/10.1053/j.gastro.2017.12.012
Gastroenterology Hadjiliadis D, Khoruts A et. al.

Dec 31st, 2017 - Improved therapy has substantially increased survival of persons with cystic fibrosis (CF). But the risk of colorectal cancer (CRC) in adults with CF is 5-10 times greater compared to the general population, and 25-30 times greater in CF patients after an organ transplantation. To address this risk, the CF Foundation convened a multi-stakeholder task force to develop CRC screening recommendatio...

AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dos...
https://aapm.onlinelibrary.wiley.com/doi/abs/10.1120/jacmp.v16i5.5768
Jennifer B. Smilowitz

Sep 7th, 2015 - The treatment planning system (TPS) is an essential component of external beam radiation therapy. TPSs are used to plan the beam arrangements, energies, field sizes, fluence patterns, and modifiers that provide optimum dose distributions to treat disease and minimize dose to the healthy tissues.

2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answ...
http://www.onlinejacc.org/content/71/2/201
Yancy, C.

Jan 7th, 2018 - The American College of Cardiology (ACC) develops a number of policy documents to provide members with guidance on clinical topics. Although clinical practice guidelines remain the primary mechanism for offering evidence-based recommendations, such guidelines may contain gaps in how to make clinical decisions, particularly when equipoise is present.

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of ...
http://www.onlinejacc.org/content/early/2018/11/02/j.jacc.2018.11.003
Grundy, S.,et al

Nov 9th, 2018 - The recommendations listed in the present guideline are, whenever possible, evidence based. An initial extensive evidence review, which included literature derived from research involving human subjects, published in English, and indexed in MEDLINE (through PubMed), EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to the present.

2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, end...
https://academic.oup.com/europace/article/20/7/1217/4939246
Bongiorni, M.

Jun 30th, 2018 - The number of cardiac implantable electronic device (CIED) implantations has increased over recent years as a result of population growth, increasing life expectancy, adoption of guidelines, and better access to healthcare. Transvenous lead extraction (TLE), as a part of an overall lead management strategy, has also been increasing, not only as a consequence of this growth, but also because of.

2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report ...
http://www.onlinejacc.org/content/early/2018/08/09/j.jacc.2018.08.1029
Stout, K.

Aug 15th, 2018 - The 2018 ACHD guideline is a full revision of the “2008 ACC/AHA Guidelines for the Management ofAdults with Congenital Heart Disease” (S1. 4-1), which was the first U.

American Heart Association (AHA) Guidelines & Statements
https://professional.heart.org/professional/GuidelinesStatements/UCM_316885_Guidelines-Statements.jsp

The American Heart Association and American Stroke Association publish medical guidelines and scientific statements on various cardiovascular disease and stroke topics. AHA/ASA volunteer scientists and healthcare professionals write the statements.

Alcoholic Liver Disease
https://www.aasld.org/sites/default/files/guideline_documents/AlcoholicLiverDisease1-2010.pdf
Robert S. O’Shea, Srinivasan Dasarathy et. al.

Dec 31st, 2009 - Alcoholic liver disease (ALD) encompasses a spectrum of injury, ranging from simple steatosis to frank cirrhosis. It may well represent the oldest form of liver injury known to humankind.

ACR Appropriateness Criteria Known or Suspected Congenital Heart Disease in the Adult
https://www.jacr.org/article/S1546-1440(17)30219-3/fulltext
Woodard, Pamela K.

Apr 30th, 2017 - The incidence of congenital heart disease (CHD) has been increasing in the adult patient population in part as a result of better patient survival. Patients with more severe CHD are living longer.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE F...
https://www.aace.com/files/hypertension-guidelines.pdf
AACE Hypertension Task Force

Mar 31st, 2006 - It is now widely appreciated that the identification and lifelong treatment of hypertension are critical to successful risk reduction in CVD. Data from the National Health and Nutrition Examination Survey, however, clearly demonstrate that treatment and control rates of hypertension have not improved substantially during the past 2 decades, despite a progressively growing and powerful armamenta.